Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughput Kinase Inhibitor Screening
Wednesday, January 21, 2026Sino Biological Inc is proud to announce the launch of its innovative SwiftFluo TRFRET Kinase Assay Kits a readytouse highperformance solution designed to accelerate kinase activity detection and highthroughput kinase inhibitor screening
Lantern Pharma's LP-284 Receives FDA Orphan Drug Designation for Soft Tissue Sarcomas
Wednesday, January 21, 2026Lantern Pharma Inc a clinicalstage biopharmaceutical company using artificial intelligence to transform the cost pace and timeline of oncology drug discovery and development today announced that the US Food and Drug Administration
ENHERTU® Plus Pertuzumab Type II Variation Application Validated in the EU as First-Line Treatment of Patients with HER2 Positive Metastatic Breast Cancer
Tuesday, January 20, 2026The European Medicines Agency EMA has validated the Type II Variation marketing authorization application for ENHERTU trastuzumab deruxtecan in combination with pertuzumab for the firstline treatment
InterAx and Alveus Announce Strategic Licensing and Research Agreement to Develop a Differentiated Therapeutic Candidate for a Metabolic Disease
Friday, January 16, 2026InterAx Biotech Ltd InterAx and Alveus Therapeutics Inc Alveus today announced a strategic licensing and research collaboration agreement to develop a differentiated small molecule candidate for metabolic disease
Making Pharmaceuticals, Distributing Pharmaceuticals and Making Nutraceuticals 2026
Friday, January 16, 2026Making Pharmaceuticals Distributing Pharmaceuticals and Making Nutraceuticals are colocated freetoattend events providing professionals from across the pharmaceutical and nutraceutical industries
Vetter Reaches Key Launch Milestones for the V-OVS® next Tamper-Evident Syringe Closure System
Friday, January 16, 2026Vetter a globally operating Contract Development and Manufacturing Organization CDMO has completed several important steps in the ongoing development and upcoming launch of VOVS next
Boehringer Ingelheim advances potential first-in-class IL-11 inhibitor to Phase II Clinical Research in Idiopathic Pulmonary Fibrosis
Wednesday, January 14, 2026Boehringer Ingelheim today announced the start of a Phase IIa clinical trial evaluating BI a novel monoclonal antibody targeting interleukin IL in patients with idiopathic pulmonary fibrosis IPF
Novotech Appoints Anand Tharmaratnam as New CEO
Tuesday, January 13, 2026Novotech a globally recognized fullservice biotech clinical research organization CRO is pleased to announce the appointment of Dr Anand Tharmaratnam as its new Chief Executive Officer
SciNeuro and Novartis Enter into a Licensing and Collaboration Agreement for Next Generation Therapeutics to Treat Alzheimer's Disease
Tuesday, January 13, 2026SciNeuro Pharmaceuticals today announced it has entered into a worldwide licensing and collaboration agreement with Novartis Pharma AG to advance SciNeuros novel amyloid beta targeted antibody program for the treatment of Alzheimers Disease
CARsgen and Dispatch Bio Announce Clinical Collaboration to Evaluate Flare Platform and Zevor-cel in Solid Tumors
Tuesday, January 13, 2026CARsgen Therapeutics Holdings Limited a company focused on developing innovative CAR Tcell therapies and Dispatch Bio a biotech company engineering a universal treatment across solid tumors leveraging its firstinclass Flare platform
